| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.56B | 5.93B | 4.84B | 2.98B | 1.48B | 1.56B |
| Gross Profit | 2.53B | 2.69B | 2.39B | 1.35B | 558.99M | 705.26M |
| EBITDA | 334.86M | 566.25M | -343.40M | -168.66M | 240.52M | 367.03M |
| Net Income | -393.13M | -177.71M | -1.13B | -574.33M | 49.40M | 207.15M |
Balance Sheet | ||||||
| Total Assets | 7.95B | 8.15B | 7.69B | 8.67B | 6.64B | 6.55B |
| Cash, Cash Equivalents and Short-Term Investments | 2.90B | 1.73B | 2.74B | 3.80B | 3.66B | 5.55B |
| Total Debt | 1.86B | 2.05B | 1.40B | 1.50B | 0.00 | 0.00 |
| Total Liabilities | 2.75B | 2.95B | 2.55B | 2.59B | 194.63M | 143.50M |
| Stockholders Equity | 4.70B | 4.64B | 4.79B | 5.87B | 6.44B | 6.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -200.24M | 20.80M | 387.11M | 186.17M | -18.82M |
| Operating Cash Flow | 0.00 | 219.03M | 464.00M | 483.38M | 198.15M | 360.70M |
| Investing Cash Flow | 0.00 | -479.27M | -1.22B | -144.47M | -2.09B | -384.52M |
| Financing Cash Flow | 0.00 | 664.63M | -303.96M | -200.78M | 1.00K | 15.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.70B | 22.28 | ― | 1.16% | 23.67% | 24.95% | |
64 Neutral | ¥10.99B | 13.40 | ― | 0.70% | 9.78% | -23.98% | |
62 Neutral | ¥11.92B | 68.83 | ― | ― | 34.56% | 4.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥51.80B | -23.80 | ― | ― | 27.58% | -1.50% | |
43 Neutral | ¥13.03B | -175.31 | ― | ― | 16.29% | 93.98% | |
41 Neutral | ¥10.88B | -27.39 | ― | ― | 22.18% | 28.27% |
HEROZ, Inc. reported a significant improvement in its financial performance for the six months ending October 31, 2025, with a 9.6% increase in net sales and substantial growth in operating and ordinary profits. Despite a slight net loss, the company shows a positive trajectory, indicating a potential strengthening of its market position and operational efficiency.
The most recent analyst rating on (JP:4382) stock is a Hold with a Yen916.00 price target. To see the full list of analyst forecasts on HEROZ, Inc. stock, see the JP:4382 Stock Forecast page.
HEROZ, Inc. has revised its full-year consolidated earnings forecast for the fiscal year ending April 2026, anticipating lower net sales and profits than initially expected. This revision is due to delays in project starts and revenue recognition in their BtoB services, as well as higher upfront investments in staffing. Despite these challenges, the company has reported growth in both the AIX and AI Security segments compared to the previous year, with BtoB services experiencing a 30% year-on-year increase. HEROZ plans to drive future growth by enhancing AI Agent functions, increasing recurring revenue, and improving security services to meet rising demand.
The most recent analyst rating on (JP:4382) stock is a Hold with a Yen916.00 price target. To see the full list of analyst forecasts on HEROZ, Inc. stock, see the JP:4382 Stock Forecast page.
HEROZ, Inc. announced a revision of the full-year earnings forecast for its subsidiary, Vario Secure Inc., for the fiscal year ending February 2026. The revised forecast indicates a decrease in expected net sales and income, with significant percentage drops across various financial metrics. This adjustment reflects challenges that may impact the company’s financial performance and stakeholder expectations.
The most recent analyst rating on (JP:4382) stock is a Hold with a Yen1162.00 price target. To see the full list of analyst forecasts on HEROZ, Inc. stock, see the JP:4382 Stock Forecast page.